Susquehanna International Group
ASTH icon

Susquehanna International Group’s Astrana Health ASTH Stock Holding History

Susquehanna International Group’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$603K Buy
24,600
+14,600
+146% +$346K ﹤0.01% 9188
2025
Q4 		$248K Sell
10,000
-1,600
-14% -$42.5K ﹤0.01% 10395
2025
Q3 		$329K Buy
+11,600
New +$314K ﹤0.01% 9906
2024
Q4 		– Sell
-5,600
Closed -$324K – 13403
2024
Q3 		$324K Buy
5,600
+100
+2% +$4.91K ﹤0.01% 9436
2024
Q2 		$223K Sell
5,500
-5,700
-51% -$226K ﹤0.01% 10114
2024
Q1 		$470K Buy
11,200
+4,100
+58% +$160K ﹤0.01% 8650
2023
Q4 		$272K Buy
+7,100
New +$236K ﹤0.01% 10024
2022
Q4 		– Sell
-28,100
Closed -$1.1M – 13872
2022
Q3 		$1.1M Sell
28,100
-1,900
-6% -$87K ﹤0.01% 6407
2022
Q2 		$1.16M Buy
30,000
+9,100
+44% +$346K ﹤0.01% 6160
2022
Q1 		$1.01M Buy
20,900
+12,200
+140% +$629K ﹤0.01% 7085
2021
Q4 		$639K Sell
8,700
-32,700
-79% -$2.69M ﹤0.01% 8495
2021
Q3 		$3.77M Buy
+41,400
New +$3.52M ﹤0.01% 4473

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group's ASTH Position: Q1 2026 in Review

Susquehanna International Group reduced its Astrana Health (ASTH) stake by 18% in Q1 2026, selling an estimated $183K and leaving 35,067 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #8276.

Susquehanna International Group first reported a position in ASTH in Q1 2018 and has held it in 22 quarters since. The position peaked at $1.74M in Q1 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Susquehanna International Group held 35,067 shares of Astrana Health worth $860K as of Q1 2026.
  • Susquehanna International Group sold 7,745 Astrana Health shares in Q1 2026, an estimated $183K.
  • Astrana Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8276 holding.
  • Susquehanna International Group first reported a position in Astrana Health in Q1 2018 and has held it in 22 quarters since.
  • Susquehanna International Group's Astrana Health position peaked at $1.74M in Q1 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.